Mitch Raponi
Impact in
- Oncology top 0.5%
- PARP inhibition in cancer therapy
- Cancer Research top 1%
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
Papers in
- Oncology 23
- PARP inhibition in cancer therapy 17
-
- Lung Cancer Treatments and Mutations 17
- Co-authors
- David G. Beer (2 shared papers)Guoan Chen (2 shared papers)Lesley Dossey (4 shared papers)Hongtao Fan (2 shared papers)Tim Jatkoe (2 shared papers)Xiaoying Wu (1 shared paper)Yixin Wang (3 shared papers)Greg M. Arndt (5 shared papers)
- Journals
- Blood (7 papers)Annals of Oncology (6 papers)European Journal of Cancer (6 papers)Cancer Discovery (3 papers)Clinical Cancer Research (3 papers)
- Partner nations
- United StatesAustraliaFrance
In The Last Decade
Mitch Raponi
54 papers receiving 7.2k citations
Mitch Raponi's Hit Papers
Peers
Comparison fields: 5 of 119
- Oncology 3.8k
- Cancer Research 1.9k
- Reproductive Medicine 1.0k
- Pulmonary and Respiratory Medicine 1.9k
- Molecular Biology 3.2k
Countries citing papers authored by Mitch Raponi
This map shows the geographic impact of Mitch Raponi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitch Raponi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitch Raponi more than expected).
Fields of papers citing papers by Mitch Raponi
This network shows the impact of papers produced by Mitch Raponi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitch Raponi. The network helps show where Mitch Raponi may publish in the future.
Co-authors
The 25 scholars most cited alongside Mitch Raponi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial Hit paper breakdown → | 2017 | 1394 |
| 2 | Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial Hit paper breakdown → | 2016 | 985 |
| 3 | Rociletinib in EGFR-Mutated Non–Small-Cell Lung Cancer Hit paper breakdown → | 2015 | 595 |
| 4 | Discovery of a Mutant-Selective Covalent Inhibitor of EGFR that Overcomes T790M-Mediated Resistance in NSCLC Hit paper breakdown → | 2013 | 564 |
| 5 | Heterogeneity Underlies the Emergence of EGFR T790 Wild-Type Clones Following Treatment of T790M-Positive Cancers with a Third-Generation EGFR Inhibitor Hit paper breakdown → | 2015 | 424 |
| 6 | 2009 | 347 | |
| 7 | 2017 | 345 | |
| 8 | 2006 | 344 | |
| 9 | 2016 | 256 | |
| 10 | 2017 | 237 | |
| 11 | 2009 | 233 | |
| 12 | 2017 | 225 | |
| 13 | 2018 | 184 | |
| 14 | 2016 | 165 | |
| 15 | 2013 | 137 | |
| 16 | 2008 | 110 | |
| 17 | 2007 | 108 | |
| 18 | 2005 | 82 | |
| 19 | 2004 | 75 | |
| 20 | 2014 | 57 |
About Mitch Raponi
Mitch Raponi is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Reproductive Medicine, Hematology and Cancer Research, having authored 56 papers that have together received 7.4k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (17 papers), Lung Cancer Treatments and Mutations (17 papers), Ovarian cancer diagnosis and treatment (6 papers), Acute Myeloid Leukemia Research (6 papers), CRISPR and Genetic Engineering (5 papers), Cancer Genomics and Diagnostics (4 papers), Plant Virus Research Studies (4 papers) and Protein Degradation and Inhibitors (4 papers). The work is most often cited by research in Oncology (3.8k citations), Cancer Research (1.9k citations), Reproductive Medicine (1.0k citations), Pulmonary and Respiratory Medicine (1.9k citations) and Molecular Biology (3.2k citations). Mitch Raponi has collaborated with scholars based in United States, Australia and France. Frequent co-authors include David G. Beer, Guoan Chen, Lesley Dossey, Hongtao Fan, Tim Jatkoe, Xiaoying Wu, Yixin Wang, Greg M. Arndt, Grace Lee and Nicholas C. Dracopoli. Their work appears in journals such as Blood, Annals of Oncology, European Journal of Cancer, Cancer Discovery and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.